Synonyms: HS-592 | meclastin | Tavegil® | Tavist®
clemastine is an approved drug (FDA (1977))
Compound class:
Synthetic organic
Comment: Marketed formulations contain clemastine hydrogen fumarate (PubChem CID 5281069).
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: clemastine |
|
No information available. |
Summary of Clinical Use |
Used to treat hay fever, rhinitis, allergic skin conditions, and pruritus |
Mechanism Of Action and Pharmacodynamic Effects |
The drug blocks the action of endogenous histamine at the histamine H1 receptor. |
External links |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com |